
WASHINGTON, DC – JULY 04: U.S. President Donald Trump, joined by Republican lawmakers, signs the “One, Big Beautiful Bill” Act into law during an Independence Day military family picnic on the South Lawn of the White House on July 04, 2025 in Washington, DC. After weeks of negotiations with Republican holdouts Congress passed the One, Big Beautiful Bill Act into law, President Trump’s signature tax and spending bill. The bill makes permanent President Donald Trump’s 2017 tax cuts, increase spending on defense and immigration enforcement and temporarily cut taxes on tips, while cutting funding for Medicaid, food assistance and other social safety net programs. (Photo by Eric Lee/Getty Images)
The recent passage of the One Big Beautiful Bill Act—what some are calling the “Big Beautiful Bill”—has ushered in one of the most significant and controversial overhauls to higher education funding in recent memory. Signed into law by President Trump on July 4, 2025, the legislation is being praised in some corners for its tax reforms and streamlined government spending. But beneath the surface, the bill threatens to widen the chasm of educational inequality, especially for low-income students in Illinois and right here in the U-46 school district, where I formerly taught.
As someone who has spent years in education and now watches from the outside with a heavy heart, I’m particularly alarmed by what this bill means for Pell Grants. These federal grants have long served as a foundation for college access among students from working-class and economically marginalized communities. In U-46, where many students are first-generation college-bound and come from families already struggling with inflation and housing costs, Pell Grants have been nothing short of essential.
The Big Beautiful Bill reduces the maximum Pell Grant award by nearly 23%, cutting it from $7,395 to $5,710 (Knott, 2025a). That shortfall is not academic—it’s rent, groceries, textbooks, and transit. Just as troubling are the new restrictions the bill imposes: students must now enroll in at least 15 credit hours to qualify for full aid, up from the previous 12. Additionally, those enrolled less than half-time—often students working jobs to support their families—will no longer be eligible. These changes are not just policy shifts; they are structural barriers that will block many Illinois students from ever setting foot on a college campus.
Illinois’ public colleges and universities have already been under financial strain for years, and state MAP grants, while helpful, are often insufficient to close the gap. For students graduating from U-46 high schools—whether in Elgin, Streamwood, Bartlett, or South Elgin—this federal retrenchment will be felt immediately. Students who were on the edge of affording their first year may now find themselves locked out of higher education altogether.
This is precisely why I launched the Katherine Walter Anthropology Scholarship Fund, hosted on Bold.org. Anthropology—my field of passion—is not often considered a “practical” major by today’s economic standards, yet it offers vital tools for understanding human behavior, culture, and history. In a time when diversity, equity, and inclusion are under attack, we need anthropologists who come from diverse economic and cultural backgrounds more than ever. My scholarship fund is a small but deliberate effort to push back against the erosion of educational access. It is designed to support students pursuing anthropology who demonstrate both academic promise and financial need—particularly those from school districts like U-46 that are too often overlooked in national education debates. You can learn more or contribute directly here: https://bold.org/funds/katherine-walter-anthropology-scholarship-fundraiser/.
This fund is not intended to be a bandage over a deep wound. Rather, it’s a gesture of solidarity with the students I once taught—those who worked double shifts to help at home, who translated school forms for their parents, who stayed late after class to ask about college but worried aloud about the cost. It’s for the ones who won’t benefit from the Big Beautiful Bill but deserve every chance to learn, grow, and contribute to the world.
While the legislation also eliminates subsidized federal student loans and imposes new performance metrics on college programs—denying eligibility to those whose graduates earn less than high school diploma holders—the burden once again falls on students. Especially those pursuing careers in social sciences, education, or the arts, where the monetary payoff may be modest, but the societal value is profound (Knott, 2025b).
If you’re someone who believes in the right to education regardless of zip code or income bracket, I invite you to act. Contribute to the scholarship. Share this message. Start a fund of your own. Because while the Big Beautiful Bill may have passed, its consequences are just beginning to unfold—and we must meet them with action, not silence.
References
Knott, K. (2025a, July 4). ‘Big, Beautiful Bill’ Means Big Changes for Higher Ed. Inside Higher Ed. https://www.insidehighered.com/news/government/politics-elections/2025/07/04/big-beautiful-bill-means-big-changes-higher-ed
Knott, K. (2025b, July 4). Trump signs ‘Big Beautiful Bill’ into law in White House ceremony. Time. https://time.com/7300177/trump-signs-big-beautiful-bill


OPM Ends Gender-Affirming Care in 2026
By Katherine Walter
On August 25, 2025
In LGBTQ+ rights
To understand the gravity of this reversal, it is necessary to recall how hard-fought the gains for transgender health care under FEHB were. In 2014, OPM lifted the longstanding blanket exclusion of gender-affirming procedures, and by 2016 carriers were instructed not to categorically deny such care. This change aligned federal benefits with emerging medical consensus that gender-affirming treatments are not elective but medically necessary. The World Professional Association for Transgender Health (WPATH) and the Endocrine Society have long affirmed that access to hormone therapy and surgeries significantly reduces psychological distress, improves quality of life, and prevents serious health complications (Hembree et al., 2017; Coleman et al., 2022). For nearly a decade, transgender federal employees and retirees could rely on this coverage as a matter of equity and recognition of their humanity.
As a transgender woman who has been receiving gender-affirming health care for more than eleven years, this policy shift strikes me not just as a bureaucratic adjustment but as a direct threat to my life and well-being. Having undergone an orchiectomy, I rely on estradiol not simply as an affirming treatment, but as essential hormone replacement. Without it, my bones, cardiovascular health, cognition, and emotional stability would be at severe risk. Estradiol for me is no different than thyroid medication for someone with hypothyroidism—it is medically necessary, lifelong care. To see it lumped under a politically charged category of “optional” transition services is both scientifically inaccurate and deeply insulting.
What unsettles me most is the uncertainty this policy creates. OPM’s promise of an “exceptions process” offers little clarity. Will it protect those of us with medical histories spanning over a decade of consistent care? Or will it force us into endless appeals and denials, treating every prescription refill as a battle? This ambiguity is destabilizing, and I cannot help but feel that it is intentional—designed to make care harder to access and to discourage providers from stepping forward.
As a federal retiree, I gave years of service under the assumption that the benefits I earned would protect me equitably. Now, I feel as though my identity has made me a target within the very system I trusted. The estimated 14,000 transgender federal employees and retirees who will be affected are not faceless statistics; we are people who dedicated our careers to serving this country, only to be told that our health care needs are unworthy of recognition (Lambda Legal, 2025; them.us, 2025). The exclusion also signals a dangerous precedent: that essential medical care can be stripped away not because of evidence or cost, but because of politics.
This change must be understood in its broader social context. Over the past decade, transgender Americans have seen both progress and backlash. The Affordable Care Act’s Section 1557 extended nondiscrimination protections in health care, and the Supreme Court’s ruling in Bostock v. Clayton County (2020) affirmed that gender identity is protected under Title VII. Yet, simultaneously, states across the country have passed laws restricting access to gender-affirming care, particularly for youth, framing these measures as cultural wedge issues. The OPM directive extends that wave of exclusion into the federal system, embedding discrimination into the nation’s largest employer-based insurance program.
For me personally, this is not an abstract policy debate. It is about whether I will be able to continue accessing the medication that keeps me healthy and alive. It is about whether the years of progress we celebrated were only temporary reprieves. And it is about what message this sends to younger transgender people entering federal service today: that their health and dignity can be used as bargaining chips in political battles.
I cannot help but feel anxious about what the future holds, but I also feel resolved. This rollback will not go unchallenged. Advocacy groups such as Lambda Legal, the National Center for Transgender Equality, and others have already condemned it as unlawful and are preparing legal strategies (Lambda Legal, 2025). As a transgender woman and a retiree, I plan to add my voice to that chorus, because silence is what allows discrimination to endure. We have fought too hard, and for too long, to let the ground be taken out from under us without resistance.
References
Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L. C., Deutsch, M. B., … Winter, S. (2022). Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health, 23(sup1), S1–S259. https://doi.org/10.1080/26895269.2022.2100644
Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., … T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 102(11), 3869–3903. https://doi.org/10.1210/jc.2017-01658
Lambda Legal. (2025, August 19). Lambda Legal condemns Trump administration’s illegal exclusion of gender-affirming care from employee health benefits. Retrieved August 22, 2025, from https://lambdalegal.org/newsroom
Moss, K. (2025, August 20). Coverage for gender-affirming care will be eliminated from FEHB plans in 2026. Government Executive. Retrieved August 22, 2025, from https://www.govexec.com
Office of Personnel Management. (2025). Carrier Letter 2025-01b: Chemical and surgical sex-trait modification exclusion. Retrieved August 22, 2025, from https://opm.gov
them.us. (2025, August 20). Trump Admin to end coverage of gender-affirming care for federal workers. them. Retrieved August 22, 2025, from https://www.them